CHLOROMETHYL 11.BETA.,17-DIHYDROXY-3-OXOANDROSTA-1,4-DIENE-17.BETA.-CARBOXYLATE, 17-(ETHYL CARBONATE)

FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments

This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s